搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Haemophilus influenzae 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (metE), partial CSB-YP332562HTA
CSB-EP332562HTA
CSB-BP332562HTA
CSB-MP332562HTA
CSB-EP332562HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Lipopolysaccharide export system permease protein lptG (lptG), partial CSB-YP332563HTA1
CSB-EP332563HTA1
CSB-BP332563HTA1
CSB-MP332563HTA1
CSB-EP332563HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Cytosol aminopeptidase (pepA) CSB-YP332564HTA
CSB-EP332564HTA
CSB-BP332564HTA
CSB-MP332564HTA
CSB-EP332564HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Transcriptional regulatory protein qseB (qseB) CSB-YP332565HTA
CSB-EP332565HTA
CSB-BP332565HTA
CSB-MP332565HTA
CSB-EP332565HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Putative ribosome biogenesis GTPase RsgA (rsgA) CSB-YP332566HTA
CSB-EP332566HTA
CSB-BP332566HTA
CSB-MP332566HTA
CSB-EP332566HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Iron-sulfur cluster insertion protein ErpA (erpA) CSB-YP332567HTA
CSB-EP332567HTA
CSB-BP332567HTA
CSB-MP332567HTA
CSB-EP332567HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae UPF0271 protein HI_1729 (HI_1729) CSB-YP332568HTA
CSB-EP332568HTA
CSB-BP332568HTA
CSB-MP332568HTA
CSB-EP332568HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pichia pastoris Histidine biosynthesis trifunctional protein (HIS4), partial CSB-YP332569EVS
CSB-EP332569EVS
CSB-BP332569EVS
CSB-MP332569EVS
CSB-EP332569EVS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Heme/hemopexin-binding protein (hxuA), partial CSB-YP332570HSZ
CSB-EP332570HSZ
CSB-BP332570HSZ
CSB-MP332570HSZ
CSB-EP332570HSZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Heme/hemopexin transporter protein huxB (hxuB), partial CSB-YP332571HSZ
CSB-EP332571HSZ
CSB-BP332571HSZ
CSB-MP332571HSZ
CSB-EP332571HSZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acetobacter pasteurianus Histidinol-phosphate aminotransferase (hisC) CSB-YP332572AVW
CSB-EP332572AVW
CSB-BP332572AVW
CSB-MP332572AVW
CSB-EP332572AVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 3-hydroxybutyryl-CoA dehydratase (crt) CSB-YP332573DUN
CSB-EP332573DUN
CSB-BP332573DUN
CSB-MP332573DUN
CSB-EP332573DUN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized 41.3 kDa protein in phbC-phbA intergenic region CSB-YP332575TOC
CSB-EP332575TOC
CSB-BP332575TOC
CSB-MP332575TOC
CSB-EP332575TOC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Allochromatium vinosum UPF0135 protein Alvin_0067 (Alvin_0067) CSB-YP332576AZP
CSB-EP332576AZP
CSB-BP332576AZP
CSB-MP332576AZP
CSB-EP332576AZP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Allochromatium vinosum Uncharacterized protein Alvin_0064 (Alvin_0064) CSB-YP332577AZP
CSB-EP332577AZP
CSB-BP332577AZP
CSB-MP332577AZP
CSB-EP332577AZP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Allochromatium vinosum Acetoacetyl-CoA reductase (phbB) CSB-YP332578AZP
CSB-EP332578AZP
CSB-BP332578AZP
CSB-MP332578AZP
CSB-EP332578AZP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Immunoglobulin A1 protease autotransporter (iga), partial CSB-YP332579HSZ
CSB-EP332579HSZ
CSB-BP332579HSZ
CSB-MP332579HSZ
CSB-EP332579HSZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Immunoglobulin A1 protease autotransporter (iga), partial CSB-YP332580HSZ
CSB-BP332580HSZ
CSB-MP332580HSZ
CSB-EP332580HSZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Adhesion and penetration protein autotransporter (hap), partial CSB-YP332581HSZ
CSB-EP332581HSZ
CSB-BP332581HSZ
CSB-MP332581HSZ
CSB-EP332581HSZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Inner membrane protein yrbG (yrbG), partial CSB-YP332582ENV
CSB-EP332582ENV
CSB-BP332582ENV
CSB-MP332582ENV
CSB-EP332582ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>